Zhang Wen-Jun, Pi Xiong-Wei, Le Yi-Guan, Li Teng-Zheng
Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang city, Jiangxi province, China.
Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang city, Jiangxi province, China.
Sci Rep. 2024 Dec 30;14(1):31673. doi: 10.1038/s41598-024-81515-7.
P2X7 receptor (P2X7R) plays a role in regulating tumor progression, but it is unclear whether P2X7R affects the pathological characteristics of patients with gastric cancer and the activity of gastric cancer cells. Therefore, this study preliminarily investigated the relationship between P2X7R and clinicopathological features of patients with gastric cancer, and further explored the effect of P2X7R on the proliferation, migration and invasion of gastric cancer cells through functional experiments. The results showed that P2X7R was highly expressed in gastric cancer tissues and gastric cancer cells. High expression of P2X7R was closely related to lymphatic metastasis, vascular invasion and Tumor-Node-Metastasis (TNM) stage in patients with gastric cancer. High expression of P2X7R predicted poor overall survival in patients. Moreover, the activation of P2X7R by ATP and its analogue BzATP increased the calcium current of gastric cancer cells, enhanced YF actin stress and cell viability, and promoted the proliferation, migration and invasion of gastric cancer cells. While P2X7R antagonists (A438079 and AZD9056) inhibited the proliferation, migration and invasion of gastric cancer cells induced by ATP. Therefore, the data obtained in this experiment suggest that P2X7R may be another potential molecular target for the prevention and treatment of gastric cancer.
P2X7受体(P2X7R)在调节肿瘤进展中发挥作用,但P2X7R是否影响胃癌患者的病理特征及胃癌细胞活性尚不清楚。因此,本研究初步探讨P2X7R与胃癌患者临床病理特征之间的关系,并通过功能实验进一步探究P2X7R对胃癌细胞增殖、迁移和侵袭的影响。结果显示,P2X7R在胃癌组织和胃癌细胞中高表达。P2X7R高表达与胃癌患者的淋巴转移、血管侵犯及肿瘤-淋巴结-转移(TNM)分期密切相关。P2X7R高表达预示患者总生存期较差。此外,ATP及其类似物BzATP对P2X7R的激活增加了胃癌细胞的钙电流,增强了YF肌动蛋白应激和细胞活力,并促进了胃癌细胞的增殖、迁移和侵袭。而P2X7R拮抗剂(A438079和AZD9056)抑制了ATP诱导的胃癌细胞增殖、迁移和侵袭。因此,本实验获得的数据表明,P2X7R可能是预防和治疗胃癌的另一个潜在分子靶点。